Education
About Us
Working with TipRanks
Follow Us
Exicure Inc (XCUR)
NASDAQ:XCUR
XCUR Stock Chart & Stats
$5.88
-$0.13(-1.36%)
At close: 4:00 PM EST
$5.88
-$0.13(-1.36%)
Day’s Range― - ―
52-Week Range$3.10 - $22.99
Previous CloseN/A
Volume39.94K
Average Volume (3M)23.77K
Market Cap
$37.73M
Enterprise Value$21.79M
Total Cash (Recent Filing)$4.44M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.34
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding6,373,869
10 Day Avg. Volume33,737
30 Day Avg. Volume23,774
Financial Highlights & Ratios
PEG Ratio0.35
Price to Book (P/B)12.31
Price to Sales (P/S)166.76
P/FCF Ratio-28.65
Enterprise Value/Market Cap0.58
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-78
Revenue Forecast (FY)$63.16M
Exicure News
XCUR FAQ
What was Exicure Inc’s price range in the past 12 months?
Exicure Inc lowest stock price was $3.10 and its highest was $22.99 in the past 12 months.
What is Exicure Inc’s market cap?
Exicure Inc’s market cap is $37.73M.
When is Exicure Inc’s upcoming earnings report date?
Exicure Inc’s upcoming earnings report date is May 20, 2026 which is in 147 days.
How were Exicure Inc’s earnings last quarter?
Exicure Inc released its earnings results on Nov 07, 2025. The company reported -$0.386 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.386.
Is Exicure Inc overvalued?
According to Wall Street analysts Exicure Inc’s price is currently Overvalued.
Does Exicure Inc pay dividends?
Exicure Inc does not currently pay dividends.
What is Exicure Inc’s EPS estimate?
Exicure Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exicure Inc have?
Exicure Inc has 6,373,869 shares outstanding.
What happened to Exicure Inc’s price movement after its last earnings report?
Exicure Inc reported an EPS of -$0.386 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.273%.
Which hedge fund is a major shareholder of Exicure Inc?
Currently, no hedge funds are holding shares in XCUR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Exicure Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 22.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.05%
12-Months-Change
Fundamentals
Return on Equity
-217.87%
Trailing 12-Months
Asset Growth
43.61%
Trailing 12-Months
Company Description
Exicure Inc
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Technical Analysis
ESSA Pharma
―
I-MAB
―
Unicycive Therapeutics
―
Caribou Biosciences
―
Vigil Neuroscience Inc
―
Ownership Overview
52.30% Insiders
0.85% Mutual Funds
4.42% Other Institutional Investors
41.89% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---